Furthermore, Li et al. [166] revealed the epidermal growth factor receptor (EGFR) as a potential biomarker candidate for the early diagnosis of breast cancer, with a sensitivity of >90% and different clinical stages of I–IV, although the AUC was ~0.7. Here, EGFR is linked to breast cancer.